More importantly, the new insights into the activation of EGFR/Akt/GSK3β signaling axis medicated by PRMT5 provide much new information for the mechanisms of the carcinogenic effect of PRMT5 in human colorectal cancer. Here, PRMT5 is linked to colorectal cancer.